{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:33:06Z","timestamp":1783031586664,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011597","name":"Department of Pharmacology, Penn State College of Medicine, and Penn State Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH's NCI Grant","doi-asserted-by":"publisher","award":["R21 CA167406-02"],"award-info":[{"award-number":["R21 CA167406-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elsa U. Pardee Foundation Grant"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T18:00:39Z","timestamp":1509818439000},"page":"1919-1930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells"],"prefix":"10.1016","volume":"143","author":[{"given":"Srinivasa Rao","family":"Ramisetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepkamal","family":"Karelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantu","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.11.006_bib1","series-title":"World Cancer Report 2014","author":"Bernard","year":"2014"},{"key":"10.1016\/j.ejmech.2017.11.006_bib2","series-title":"Cancer Facts & Figures\u00a02016","author":"Society","year":"2016"},{"key":"10.1016\/j.ejmech.2017.11.006_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nature09454","article-title":"Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma","volume":"467","author":"Bollag","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2017.11.006_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1758834015616934","article-title":"Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy","volume":"8","author":"Eroglu","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejmech.2017.11.006_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.11.006_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bmc.2003.08.035","article-title":"Synthesis of some newer derivatives of substituted quinazolinonyl-2-oxo\/thiobarbituric acid as potent anticonvulsant agents","volume":"12","author":"Archana","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0223-5234(98)80002-0","article-title":"Anti-inflammatory, analgesic and antipyretic activity of some new 1-(pyrimidin-2-yl)-3-pyrazoline-5-ones and 2-(pyrimidin-2-yl)-1, 2, 4, 5, 6, 7-hexahydro-3H-indazol-3-ones","volume":"33","author":"Badawey","year":"1998","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib8","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.bmc.2007.03.024","article-title":"Synthesis and biological evaluation of new 3-substituted indole derivatives as potential anti-inflammatory and analgesic agents","volume":"15","author":"Radwan","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/00397911.2011.611324","article-title":"Synthesis of some novel pyrimidinedione and pyrimidinetrione derivatives by a greener method: study of their antimicrobial activity and photophysical properties","volume":"43","author":"Borse","year":"2013","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2017.11.006_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5155\/eurjchem.6.1.63-70.1147","article-title":"Synthesis of some new fluorine substituted thiobarbituric acid derivatives as anti HIV1 and cyclin-dependent kinase 2 (CDK2) for cell tumor division: Part I","volume":"6","author":"Al-Harbi","year":"2015","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib11","first-page":"787","article-title":"Synthesis and anticonvulsant activity of 1-acetyl-5-arylidenyl-3-(2\u2032-oxo\/thio-barbiturinyl)-2-pyrazolines","volume":"52","author":"Srivastava","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2017.11.006_bib12","article-title":"Substituted thiobarbituric acids as anti-parkinsonian agents","volume":"15","author":"Kumar","year":"1984","journal-title":"Chem. Inf."},{"key":"10.1016\/j.ejmech.2017.11.006_bib13","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0960-894X(99)00238-3","article-title":"Uridine phosphorylase inhibitors: chemical modification of benzyloxybenzyl-barbituric acid and its effects on urdpase inhibition","volume":"9","author":"Guerin","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.11.006_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00044-013-0683-4","article-title":"Design and synthesis of novel nucleobase-based barbiturate derivatives as potential anticancer agents","volume":"23","author":"Dhorajiya","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2017.11.006_bib15","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1016\/j.bmcl.2015.10.088","article-title":"PPL catalyzed four-component PASE synthesis of 5-monosubstituted barbiturates: structure and pharmacological properties","volume":"25","author":"Bihani","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.11.006_bib16","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1039\/c2ob26081f","article-title":"Development of a novel class of B-Raf v600e-selective inhibitors through virtual screening and hierarchical hit optimization","volume":"10","author":"Kong","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bmcl.2012.12.053","article-title":"5-((1-Aroyl-1H-indol-3-yl) methylene)-2-thioxodihydropyrimidine-4, 6 (1H, 5H)-diones as potential anticancer agents with anti-inflammatory properties","volume":"23","author":"Penthala","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.11.006_bib18","first-page":"2578","article-title":"In\u00a0vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone","volume":"49","author":"Drake","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2017.11.006_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1562\/2005-09-02-RA-672","article-title":"Potentiation of the antitumor effect of merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B","volume":"82","author":"Tsujino","year":"2006","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2017.11.006_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1751-1097.2012.01078.x","article-title":"Photochemically generated elemental selenium forms conjugates with serum proteins that are preferentially cytotoxic to leukemia and selected solid tumor cells","volume":"88","author":"Daziano","year":"2012","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2017.11.006_bib21","doi-asserted-by":"crossref","first-page":"e108166","DOI":"10.1371\/journal.pone.0108166","article-title":"Characterization of a novel anti-cancer compound for astrocytomas","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2017.11.006_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2017.11.006_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2017.11.006_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cbi.2010.09.021","article-title":"Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib","volume":"188","author":"Desai","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2017.11.006_bib25","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1016\/j.bmc.2005.06.011","article-title":"Synthesis and evaluation of antioxidative properties of a series of organoselenium compounds","volume":"13","author":"Hossain","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib26","doi-asserted-by":"crossref","first-page":"10057","DOI":"10.1158\/0008-5472.CAN-06-1814","article-title":"Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells","volume":"66","author":"Hwang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2017.11.006_bib27","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2174\/138955708785740625","article-title":"Selenium compounds and apoptotic modulation: a new perspective in cancer therapy","volume":"8","author":"Sanmartin","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib28","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1158\/1535-7163.MCT-07-2267","article-title":"PBISe, a novel selenium-containing drug for the treatment of malignant melanoma","volume":"7","author":"Madhunapantula","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2017.11.006_bib29","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/acs.jmedchem.5b01503","article-title":"Design, synthesis, and biological evaluation of novel selenium (Se-NSAID) molecules as anticancer agents","volume":"59","author":"Plano","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbi.2012.08.022","article-title":"Phenylalkyl isoselenocyanates vs phenylalkyl isothiocyanates: thiol reactivity and its implications","volume":"200","author":"Crampsie","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2017.11.006_bib31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/1940-6207.CAPR-10-0106","article-title":"Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4","volume":"4","author":"Nguyen","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ejmech.2017.11.006_bib32","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1021\/jm800993r","article-title":"Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates","volume":"51","author":"Sharma","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/chem.19970030717","article-title":"Large quadratic hyperpolarizabilities with donor\u2013acceptor polyenes exhibiting optimum bond length alternation: correlation between structure and hyperpolarizability","volume":"3","author":"Blanchard-Desce","year":"1997","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.ejmech.2017.11.006_bib34","volume":"73","author":"Brooker","year":"1951","journal-title":"Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.11.006_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejmech.2010.11.013","article-title":"Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates","volume":"46","author":"Ibanez","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.11.006_bib36","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1016\/j.bmcl.2010.05.094","article-title":"Synthesis of isosteric selenium analog of the PPARbeta\/delta agonist GW501516 and comparison of biological activity","volume":"20","author":"Sharma","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.11.006_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ph9010011","article-title":"Targeting cell survival proteins for cancer cell death","volume":"9","author":"Pandey","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2017.11.006_bib38","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1021\/ja01532a037","article-title":"2-Selenobarbiturates. Studies of some analogous oxygen, sulfur and selenium compounds","volume":"81","author":"Mautner","year":"1959","journal-title":"J.\u00a0Am. Chem. Soc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T11:33:47Z","timestamp":1582544027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417308917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":38,"alternative-id":["S0223523417308917"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.006","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}